UNSPSC 51453101: Morantel

This classification denotes an antihelminthic agent with the molecular formula C12H16N2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 7NJ031HAX5 chemically known as (e)-1,4,5,6-tetrahydro-1-methyl-2-(2-(3-methyl-2-thienyl)vinyl)pyrimidine but generally known as morantel, which bears US NIH Compound Identifier 5353792. European Medicines Agency schedules Morantel in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09063MIG. The term MORANTEL is an International Non-Proprietary Name or INN.

Most nations schedule morantel under HS 29349990 and SITC 51579. As of Q4 2014, MORANTEL remains the US FDA Preferred Term for this commodity. Morantel bears US NLM identifiers UMLS ID C0026534 and NCI Concept Code C75221. SMILES: CC1=C(SC=C1)/C=C/C2=NCCCN2C.

UNSPSC 51453101 Morantel is a Commodity code covering pharmaceutical products and related medical supplies procured by state and local health agencies, emergency services, and cooperative purchasing alliances. Recent state and local solicitations under this code reflect a diverse procurement mix: emergency medical supplies for fire rescue divisions, naloxone and drug deactivation systems for county health initiatives, generic pharmaceutical products distributed through state multistate cooperatives, and direct-to-manufacturer prescription programs. The issuing bodies span municipal fire departments, county health agencies, state health commissions, and state-administered cooperative purchasing alliances serving multiple jurisdictions. Scope reflects both high-volume consumables (respiratory equipment, bandaging materials, oxygen delivery systems, endotracheal tubes) and specialized pharmaceutical products (naloxone, generic multi-source drugs, OTC products) with requirements for FDA compliance, expiration-date management, and supply-chain security certification.

Recent activity concentrates in Florida and the Upper Midwest. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026 (due July 26, 2023) for 1,900 units of naloxone and 800 drug deactivation systems annually with quarterly deliveries to Sanford, Florida—a two-year contract with one-year renewal option. The City of Tampa issued IFB 26P00145 on March 25, 2026 (due March 13, 2026) for 169 line items of medical and first aid supplies for its fire rescue division, estimated at $700,000, designated as a sheltered market for certified Small Local Business Enterprises with a 5 percent bid discount. Minnesota's multistate cooperative purchasing alliance (MMCAP) issued RFP S1070000015802 on January 20, 2026 (due March 26, 2026) to establish multiple generic pharmaceutical and OTC product contracts effective July 1, 2026, drawing participation from Minnesota and Oregon. Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026 to explore direct-to-manufacturer prescription program capabilities, signaling exploratory procurement ahead of formal competitive solicitation. Contracts typically include firm pricing for one or more years, require compliance with supply-chain security regulations, and mandate delivery within five working days; SLBE set-asides and cooperative purchasing vehicles appear regularly in municipal and county activity.